Position in CGC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,914
+$36 QoQ
Shares Held
16,752
+0.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 212 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $43,412,538 across 29 Drug Manufacturers - Specialty & Generic names. CGC ranks #29 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
121,151 | $8,705,910 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
45,360 | $7,644,974 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9,855 | $5,339,734 | |
| 4 | VTRS |
Viatris Inc
|
197,717 | $3,139,745 | |
| 5 | HLN |
Haleon plc
|
263,202 | $2,455,674 | |
| 6 | HROW |
Harrow, Inc.
|
56,414 | $2,395,902 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
143,998 | $2,308,287 | |
| 8 | ALKS |
Alkermes plc.
|
42,278 | $2,215,367 |
All Filings in CGC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,914 | 16,752 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $15,878 | 16,732 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,373 | 26,643 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $28,176 | 19,299 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $14,879 | 12,196 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $12,182 | 13,387 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $37,453 | 13,669 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $83,805 | 17,387 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $108,695 | 16,852 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $136,906 | 15,864 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $91,525 | 17,911 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $127,941 | 163,399 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $60,118 | 154,944 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $272,900 | 155,943 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $348,287 | 150,774 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $475,694 | 174,247 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $17,461 | 6,127 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $61,307 | 8,088 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $85,318 | 9,773 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $164,171 | 11,845 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $312,478 | 12,923 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $311,075 | 9,712 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $306,595 | 12,443 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $110,793 | 7,737 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $140,882 | 8,718 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $89,101 | 6,179 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||